MYELODYSPLASTIC SYNDROME

This adverse event was reported 14478 times

These drugs are most commonly taken by patients reporting MYELODYSPLASTIC SYNDROME:

# Drug Count
0 CYCLOPHOSPHAMIDE 2336
1 CYCLOPHOSPHAMIDE FOR INJECTION 2336
2 CYCLOPHOSPHAMIDE INJECTION, SOLUTION 2336
3 LENALIDOMIDE 2178
4 RITUXIMAB 1445
5 ETOPOSIDE 1218
6 DOXORUBICIN 1189
7 PREDNISONE 1141
8 METHOTREXATE SODIUM 1128
9 DEXAMETHASONE 1120
See all common drugs associated with MYELODYSPLASTIC SYNDROME

MYELODYSPLASTIC SYNDROME is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 IBRITUMOMAB TIUXETAN 98 0.0643
1 CARMUSTINE 301 0.0638
2 INDIUM IN -111 PENTETREOTIDE 6 0.0469
3 MITOXANTRONE HYDROCHLORIDE 237 0.0377
4 IDECABTAGENE VICLEUCEL 38 0.0306
5 BREXUCABTAGENE AUTOLEUCEL 65 0.0301
6 AXICABTAGENE CILOLEUCEL 295 0.0290
7 LUSPATERCEPT 75 0.0287
8 MELPHALAN HYDROCHLORIDE 722 0.0285
9 AZACITIDINE 780 0.0259
See all drugs enriched for association with MYELODYSPLASTIC SYNDROME